Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01819129

Public ClinicalTrials.gov record NCT01819129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, Europe and North America. The aim of the trial is to compare FIAsp (faster-acting insulin aspart) to insulin aspart, both in combination with insulin glargine and metformin in adults with type 2 diabetes.

Study identification

NCT ID
NCT01819129
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
881 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 9, 2013 (Actual)
Primary completion
Jan 22, 2015 (Actual)
Completion
Jan 22, 2015 (Actual)
Last update posted
Jan 30, 2019

2013 – 2015

United States locations

U.S. sites
77
U.S. states
27
U.S. cities
71
Facility City State ZIP Site status
Novo Nordisk Investigational Site Glendale Arizona 85306-4652 —
Novo Nordisk Investigational Site Glendale Arizona 85308 —
Novo Nordisk Investigational Site Mesa Arizona 85213 —
Novo Nordisk Investigational Site Phoenix Arizona 85020 —
Novo Nordisk Investigational Site Tempe Arizona 85283 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Greenbrae California 94904 —
Novo Nordisk Investigational Site Lomita California 90717 —
Novo Nordisk Investigational Site Northridge California 91325 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site San Ramon California 94583 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Aurora Colorado 80045 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80910 —
Novo Nordisk Investigational Site Waterbury Connecticut 06708 —
Novo Nordisk Investigational Site Boynton Beach Florida 33472 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Cooper City Florida 33024 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316 —
Novo Nordisk Investigational Site Jacksonville Florida 32205 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Miami Florida 33144 —
Novo Nordisk Investigational Site Miami Florida 33173 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33027 —
Novo Nordisk Investigational Site Plantation Florida 33324 —
Novo Nordisk Investigational Site Tampa Florida 33603 —
Novo Nordisk Investigational Site Atlanta Georgia 30308-2253 —
Novo Nordisk Investigational Site Atlanta Georgia 30328 —
Novo Nordisk Investigational Site Decatur Georgia 30033 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Avon Illinois 46123 —
Novo Nordisk Investigational Site Peoria Illinois 61602 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Louisville Kentucky 40206 —
Novo Nordisk Investigational Site Madisonville Kentucky 42431-1661 —
Novo Nordisk Investigational Site Paducah Kentucky 42003 —
Novo Nordisk Investigational Site Monroe Louisiana 71203 —
Novo Nordisk Investigational Site Buckley Michigan 49620 —
Novo Nordisk Investigational Site Detroit Michigan 48201 —
Novo Nordisk Investigational Site Troy Michigan 48085-5524 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Butte Montana 59701 —
Novo Nordisk Investigational Site Elkhorn Nebraska 68022 —
Novo Nordisk Investigational Site Omaha Nebraska 68105 —
Novo Nordisk Investigational Site Omaha Nebraska 68198-3020 —
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050 —
Novo Nordisk Investigational Site Mineola New York 11501 —
Novo Nordisk Investigational Site New Windsor New York 12553 —
Novo Nordisk Investigational Site North Massapequa New York 11758-1802 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site Hickory North Carolina 28601 —
Novo Nordisk Investigational Site Wilmington North Carolina 28401 —
Novo Nordisk Investigational Site Carlisle Ohio 45005 —
Novo Nordisk Investigational Site Cleveland Ohio 44122 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Franklin Ohio 45005 —
Novo Nordisk Investigational Site Mason Ohio 45040-6815 —
Novo Nordisk Investigational Site East Providence Rhode Island 02914 —
Novo Nordisk Investigational Site Gaffney South Carolina 29341 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404-1192 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Spring Hill Tennessee 37174 —
Novo Nordisk Investigational Site Tullahoma Tennessee 37388 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75251 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site Murray Utah 84123 —
Novo Nordisk Investigational Site Midlothian Virginia 23114 —
Novo Nordisk Investigational Site Port Orchard Washington 98366 —
Novo Nordisk Investigational Site Kenosha Wisconsin 53144 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01819129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01819129 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →